Reference
Quartuccio L, et al. Cost-effectiveness analysis of two rituximab retreatment regimens for longstanding rheumatoid arthritis. Arthritis care and research : 7 Jan 2015. Available from: URL: http://doi.org/10.1002/acr.22534
Rights and permissions
About this article
Cite this article
Rituximab re-treatment as needed preferred option in RA. PharmacoEcon Outcomes News 720, 29 (2015). https://doi.org/10.1007/s40274-015-1868-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-1868-5